1. Home
  2. SLN vs LOVE Comparison

SLN vs LOVE Comparison

Compare SLN & LOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLN
  • LOVE
  • Stock Information
  • Founded
  • SLN 1994
  • LOVE 1998
  • Country
  • SLN United Kingdom
  • LOVE United States
  • Employees
  • SLN N/A
  • LOVE N/A
  • Industry
  • SLN Biotechnology: Pharmaceutical Preparations
  • LOVE Other Specialty Stores
  • Sector
  • SLN Health Care
  • LOVE Consumer Discretionary
  • Exchange
  • SLN Nasdaq
  • LOVE Nasdaq
  • Market Cap
  • SLN 273.9M
  • LOVE 298.3M
  • IPO Year
  • SLN N/A
  • LOVE 2018
  • Fundamental
  • Price
  • SLN $6.11
  • LOVE $18.51
  • Analyst Decision
  • SLN Buy
  • LOVE Strong Buy
  • Analyst Count
  • SLN 5
  • LOVE 5
  • Target Price
  • SLN $32.60
  • LOVE $30.40
  • AVG Volume (30 Days)
  • SLN 105.4K
  • LOVE 276.7K
  • Earning Date
  • SLN 08-14-2025
  • LOVE 09-11-2025
  • Dividend Yield
  • SLN N/A
  • LOVE N/A
  • EPS Growth
  • SLN N/A
  • LOVE N/A
  • EPS
  • SLN N/A
  • LOVE 0.82
  • Revenue
  • SLN $27,701,000.00
  • LOVE $686,358,000.00
  • Revenue This Year
  • SLN N/A
  • LOVE $6.64
  • Revenue Next Year
  • SLN N/A
  • LOVE $7.24
  • P/E Ratio
  • SLN N/A
  • LOVE $22.47
  • Revenue Growth
  • SLN N/A
  • LOVE N/A
  • 52 Week Low
  • SLN $1.97
  • LOVE $12.12
  • 52 Week High
  • SLN $22.47
  • LOVE $39.49
  • Technical
  • Relative Strength Index (RSI)
  • SLN 55.70
  • LOVE 50.38
  • Support Level
  • SLN $6.10
  • LOVE $17.31
  • Resistance Level
  • SLN $6.67
  • LOVE $18.41
  • Average True Range (ATR)
  • SLN 0.39
  • LOVE 0.81
  • MACD
  • SLN -0.02
  • LOVE 0.00
  • Stochastic Oscillator
  • SLN 59.70
  • LOVE 57.08

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

About LOVE The Lovesac Company

The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.

Share on Social Networks: